|
ACHL
|
Achilles Therapeutics plc
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
ADCT
|
ADC Therapeutics SA
|
US
|
NYSE
|
|
AEZS
|
AEterna Zentaris Inc.
|
US
|
NASDAQ
|
|
AFMD
|
Affimed Therapeutics B.V.
|
US
|
NASDAQ
|
|
AGLE
|
Aeglea BioTherapeutics, Inc.
|
US
|
NASDAQ
|
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
US
|
NASDAQ
|
|
ANIX
|
Anixa Biosciences, Inc.
|
US
|
NASDAQ
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
ARAY
|
Accuray Incorporated
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
|
BLCM
|
Bellicum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BPTH
|
Bio-Path Holdings Inc
|
US
|
NASDAQ
|